Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 2018;68(6):394-424.
DOI: 10.3322/caac.21492
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: A Cancer Journal for Clinicians 2019;69(1):7-34.
DOI: 10.3322/caac.21551
GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterology Hepatology 2019;4 12):934-47.
McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journol of Gastroenterology 2018;24(43):4846-61.
DOI: 10.3748/wjg.v24.i43.4846
Minicozzi P, Cassetti T, Vener C, Sant M. Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates. Cancer Epidemiology 2018;55:52-60.
DOI: 10.1016/j.canep.2018.04.011
Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World Journal of Oncolology 2019;10:10-27.
DOI: 10.14740/wjon1166
Klee J, Korc M, Apte M, La Vecchia C, Johnson CD, et al. Pancreatic cancer. Nature Reviews Disease Primers 2016;2:1-23.
Lin Y, Yagyu K, Egawa N, Ueno M, Nkao H, et al. An Overview of Genetic Polymorphisms and Pancreatic Cancer Risk in Molecular Epidemiologic Studies, Journal of Epidemiology 2011;21(1):2-12.
DOI: 10.2188/jea.JE20100090
Kimura K, Amano R, Nakata B, Yamazoe S, Hirata K, et al. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. World Journal of Surgical Oncology 2014;12:360.
DOI: 10.1186/1477-7819-12-360
Khomiak A, Brunner M, Kordes M, Lindblad S, Miksch RC, et al. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers (Basel) 2020;12(11):3234.
DOI: 10.3390/cancers12113234
Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clinical Nutrition 2008;27:398-407.
DOI: 10.1016/j.clnu.2008.03.002
Alifano M, Mansuet-Lupo A, Lococo F, Roche N, Bobbio A, et al. Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected nonsmall cell lung cancer. PLoS One 2014;9:e106914.
DOI: 10.1371/journal.pone.0106914
Schwegler I, von Holzen A, Gutzwiller JP, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. British Journal of Surgery 2010;97(1):92-77.
DOI: 10.1002/bjs.6805
Menezes TM, Dias MO, Reis R, Elias J, Lucchesi FR, Araujo RLC. Prognostic value of muscle depletion assessed by computed tomography for surgical outcomes of cancer patients undergoing total esophagectomy and gastrectomy. Journal of Surgical Oncology 2020;121:814-22.
DOI: 10.1002/jso.25822
Deng HY, Zha P, Peng L, Hou L, Huang KL, Li XY. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: A comprehensive systematic review and meta-analysis. Diseases of the Esophagus 2019;32(3):115.
DOI: 10.1093/dote/doy115
Grün J, Elfinger L, Le H, Weiß C, Otto M, Reißfelder C, Blank S. The Influence of Pretherapeutic and Preoperative Sarcopenia on Short-Term Outcome after Esophagectomy. Cancers (Basel) 2020;12(11):3409.
DOI: 10.3390/cancers12113409
Oshima M, Okano K, Suto H, Ando Y, Kamada H, Masaki T, et al. Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer. BMC Gastroenterology 2020;20(1):423.
DOI: 10.1186/s12876-020-01566-8
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 1984;85(9):1001-5.
Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer 2019;22(1):10-22.
DOI: 10.1007/s10120-018-0882-2
Bosman FT, Carneiro F, Hruban R H, Theise N. WHO classification of tumours of the digestive system, fourth edition. France: IARC; 2010. Available from: http://www.ncbi.nlm.nih.gov/nlmcatalog/101553728.
Hopkinson JB, Wright DN, McDonald JW, Corner JL. The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. Journal of Pain and Symptom Management 2006;32(4):322-31.
DOI: 10.1016/j.jpainsymman.2006.05.012
Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. Journal of Gastrointestinal Surgery 2008;12(7):1193-201.
DOI: 10.1007/s11605-008-0505-z
Geng Y, Qi Q, Sun M. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Europen Journal of Surgical Oncology 2015;41:1508-14.
DOI: 10.1016/j.ejso.2015.07.022
Bicakli DH, Uslu R, Güney SC, Coker A. The Relationship Between Nutritional Status, Performance Status, and Survival Among Pancreatic Cancer Patients. Nutrition and Cancer 2020;72(2):202-8.
DOI: 10.1080/01635581.2019.1634217
Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. Journal of Gastrointestinal Surgery 2012;16(8):1478-86.
DOI: 10.1007/s11605-012-1923-5
Bruenderman EH, Martin RC. High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening. Journal of Surgical Research 2015;194(1):212-9.
DOI: 10.1016/j.jss.2014.06.046
Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica et Biophysica Acta 2011;1815(1):44-64.
Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, et al. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Scientific Reports 2020;10(1):18758.
DOI: 10.1038/s41598-020-75745-8